𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation

✍ Scribed by Coluccia, Addolorata Maria Luce; Vacca, Angelo; Duñach, Mireia; Mologni, Luca; Redaelli, Sara; Bustos, Victor H; Benati, Daniela; Pinna, Lorenzo A; Gambacorti-Passerini, Carlo

Book ID
110031865
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
541 KB
Volume
26
Category
Article
ISSN
0261-4189

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bcr-Abl-induced tyrosine phosphorylation
Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells
✍ Jing-Yi Chen; Ming-Chung Wang; Wen-Chun Hung 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

## Abstract Our previous study demonstrates that Bcr‐Abl fusion oncogene frequently found in chronic myeloid leukemia (CML) cells can up‐regulate Skp2 expression via transcriptional activation. However, Bcr‐Abl also modulates Skp2 protein stability in these cells. Treatment of Bcr‐Abl kinase inhibi

Bcr-Abl oncogene stimulates jab1 express
Bcr-Abl oncogene stimulates jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells
✍ Kuei-Ting Yang; Ming-Chung Wang; Jing-Yi Chen; Ming-Chuan Hsu; Wen-Chun Hung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB

## Abstract Jab1, a co‐activator of AP‐1 transcription factor and the fifth subunit of the COP9 signalosome, mediates degradation of the tumor suppressor p53 and p27^Kip1^ and functions as a tumor promoter in different types of human cancer. In this study, we show that inhibition of Bcr‐Abl oncogen